Renaissance Technologies’s Meihua International Medical Technologies MHUA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-306
Closed -$11.1K 3554
2025
Q3
$11.1K Buy
306
+65
+27% +$2.66K ﹤0.01% 3447
2025
Q2
$9.64K Buy
241
+117
+94% +$4.32K ﹤0.01% 3509
2025
Q1
$4.16K Buy
+124
New +$4.09K ﹤0.01% 3402
2024
Q4
Sell
-132
Closed -$13.5K 3773
2024
Q3
$13.5K Sell
132
-111
-46% -$10.2K ﹤0.01% 3449
2024
Q2
$20.7K Sell
243
-13
-5% -$932 ﹤0.01% 3382
2024
Q1
$19K Sell
256
-454
-64% -$40.1K ﹤0.01% 3593
2023
Q4
$105K Buy
+710
New +$130K ﹤0.01% 3294

Renaissance Technologies's MHUA Position: Q4 2025 in Review

Renaissance Technologies sold out of Meihua International Medical Technologies (MHUA) in Q4 2025, closing a stake of 306 shares — an estimated $11.1K sold.

Renaissance Technologies first reported a position in MHUA in Q4 2023 and held it in 7 quarters. The position peaked at $105K in Q4 2023. 0 funds tracked by Wall St. Rank hold MHUA as of Q4 2025.

  • Renaissance Technologies reported no remaining Meihua International Medical Technologies position as of Q4 2025 after selling out during the quarter.
  • Renaissance Technologies sold 306 Meihua International Medical Technologies shares in Q4 2025, an estimated $11.1K.
  • Renaissance Technologies first reported a position in Meihua International Medical Technologies in Q4 2023 and held it in 7 quarters.
  • Renaissance Technologies's Meihua International Medical Technologies position peaked at $105K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q4 2025.

Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.